| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0009-9120(92)90354-U |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000991209290354U?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:000991209290354U?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1633638 |
| P2093 | author name string | R. L. Rubin | |
| P2860 | cites work | Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin | Q34194662 |
| Oxygen-dependent microbial killing by phagocytes (first of two parts). | Q34381571 | ||
| Origins of anti-DNA autoantibodies | Q34528072 | ||
| Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro | Q34571027 | ||
| Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies | Q36354257 | ||
| Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus | Q37031378 | ||
| Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells | Q37403296 | ||
| Hepatic drug metabolism and ageing | Q38141029 | ||
| Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome | Q38596014 | ||
| Drug-induced systemic lupus erythematosus: A critical review | Q39339269 | ||
| Antibodies to Nuclear Antigens in Patients Treated with Procainamide or Acetylprocainamide | Q39575045 | ||
| The histone core complex: an octamer assembled by two sets of protein-protein interactions | Q44835498 | ||
| Serologic changes during induction of lupus-like disease by procainamide | Q45235893 | ||
| Subnucleosome structures as substrates in enzyme-linked immunosorbent assays | Q46566823 | ||
| Pseudoautoimmunity in normal mice: anti-histone antibodies elicited by immunization versus induction during graft-versus-host reaction | Q46663185 | ||
| A new procedure for the isolation and fractionation of histones. | Q54047075 | ||
| Procainamide hydroxylamine lymphocyte toxicity—I. Evidence for participation by hemoglobin | Q56474599 | ||
| Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide | Q56474600 | ||
| Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus | Q68093472 | ||
| Immunization with the Sm nuclear antigen induces anti-Sm antibodies in normal and MRL mice | Q68101041 | ||
| Anti-Ro (SS-A) antibodies from Ro (SS-A)-immunized mice | Q68283335 | ||
| Spectropolarimetric analysis of the core histone octamer and its subunits | Q68510728 | ||
| Procainamide elicits a selective autoantibody immune response | Q68795199 | ||
| Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone | Q68943178 | ||
| Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus | Q68998560 | ||
| Spectroscopic studies on histone-DNA interactions. I. The interaction of histone (H2A, H2B) dimer with DNA: DNA sequence dependence | Q69403264 | ||
| Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis | Q69866144 | ||
| The formation of procainamide hydroxylamine by rat and human liver microsomes | Q69895895 | ||
| Drug-induced autoimmune disease | Q70020608 | ||
| Subnucleosomes and their relationships to the arrangement of histone binding sites along nucleosome deoxyribonucleic acid | Q70472862 | ||
| Responsiveness of autoimmune and normal mice to nucleic acid antigens | Q71251892 | ||
| Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes | Q72572782 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoantibody | Q785022 |
| antibody specificity | Q60341073 | ||
| P304 | page(s) | 223-234 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs | |
| P478 | volume | 25 |
| Q42824785 | Changes in DNA supercoiling in fibroblasts cultured in the presence of hydralazine. |
| Q24812509 | Clinical and laboratory characteristics of drug-induced vasculitic syndromes |
| Q88995636 | Drug-induced lupus erythematosus: an update on drugs and mechanisms |
| Q44553038 | Frequency and significance of antibodies to chromatin in autoimmune hepatitis |
| Q60046064 | Human Chorionic Gonadotropin Influences Systemic Autoimmune Responses |
| Q50944728 | Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. |
| Q41605526 | The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus. |
Search more.